These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21729029)

  • 1. Phenotypic analysis in a case of hydroa vacciniforme-like eruptions associated with chronic active Epstein-Barr virus disease of γδ T cells.
    Tanaka C; Hasegawa M; Fujimoto M; Iwatsuki K; Yamamoto T; Yamada K; Kawa K; Saikawa Y; Toga A; Mase S; Wada T; Takehara K; Yachie A
    Br J Dermatol; 2012 Jan; 166(1):216-8. PubMed ID: 21729029
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroa vacciniforme-like Epstein-Barr virus-associated lymphoproliferative disease: a case report.
    Zeng Y; Fu L; Jin H; Sun Q; Wang B
    Pediatr Dermatol; 2012; 29(1):96-100. PubMed ID: 21995788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.
    Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY
    Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral treatment of a boy with EBV-associated hydroa vacciniforme.
    Pahlow Mose A; Fisker N; Clemmensen O; Bygum A
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25422336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
    Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
    Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral therapy in children with hydroa vacciniforme.
    Lysell J; Wiegleb Edström D; Linde A; Carlsson G; Malmros-Svennilson J; Westermark A; Andersson J; Wahlgren CF
    Acta Derm Venereol; 2009; 89(4):393-7. PubMed ID: 19688153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
    Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
    Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up.
    Verneuil L; Gouarin S; Comoz F; Agbalika F; Creveuil C; Varna M; Vabret A; Janin A; Leroy D
    Br J Dermatol; 2010 Jul; 163(1):174-82. PubMed ID: 20367637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders.
    Iwatsuki K; Miyake T; Hirai Y; Yamamoto T
    Eur J Dermatol; 2019 Feb; 29(1):21-28. PubMed ID: 30998212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells.
    Hirai Y; Yamamoto T; Kimura H; Ito Y; Tsuji K; Miyake T; Morizane S; Suzuki D; Fujii K; Iwatsuki K
    J Invest Dermatol; 2012 May; 132(5):1401-8. PubMed ID: 22297643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroa vacciniforme present for 48 years with cytotoxic CD4+ T-cell infiltration and Epstein-Barr virus infection.
    Xie JL; Chen GY; Jin Y; Zheng XD; Wei XJ; Zheng YY; Zhang SH; Zhang YN; Zhang XJ; Zhou XG
    Br J Dermatol; 2012 Feb; 166(2):449-51. PubMed ID: 21801161
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroa vacciniforme-like lymphoproliferative disorder: A study of clinicopathology and whole-exome sequencing in Chinese patients.
    Xie Y; Wang T; Wang L
    J Dermatol Sci; 2020 Aug; 99(2):128-134. PubMed ID: 32682634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts.
    Yamamoto T; Tsuji K; Suzuki D; Morizane S; Iwatsuki K
    J Microbiol Methods; 2007 Feb; 68(2):403-7. PubMed ID: 17141343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein-Barr Virus Infection.
    Chen CC; Chang KC; Medeiros LJ; Lee JY
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial reproduction of atypical hydRoa vacciniforme caused by latent EpStein-Barr virus infection.
    Heo EP; Park SH; Kim TH
    Int J Dermatol; 2003 Jun; 42(6):476-9. PubMed ID: 12854510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroa vacciniforme-like lymphoproliferative disorder in Ecuadorian children: A case series.
    Garzón E; Dávila-Rodríguez JJ
    Indian J Dermatol Venereol Leprol; 2023; 89(3):403-407. PubMed ID: 33871198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children.
    Xu Z; Lian S
    Pediatr Dermatol; 2010; 27(5):463-9. PubMed ID: 20497358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
    Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
    Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematous presenting with hydroa vacciniforme-like eruption: mimicking Epstein-Barr virus-associated lymphoproliferative disorders.
    Noh TK; Haw S; Soung JH; Won CH; Chang S; Choi JH; Moon KC; Park YS; Lee MW
    J Dermatol; 2012 Dec; 39(12):1095-7. PubMed ID: 22937887
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroa vacciniforme-like lymphoma misdiagnosed as cutaneous lupus erythematosus.
    Kim TH; Lee JH; Kim YC; Lee SE
    J Cutan Pathol; 2015 Mar; 42(3):229-231. PubMed ID: 25488018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.